ÂÜÀòÂÒÂ×

Fernando Eguiarte-Solomon has a diverse work experience in the field of oncology and pharmaceutical sciences. Fernando is currently working as the Director of Study Operations at Certis Oncology Solutions, Inc. starting in 2022. Prior to this role, they had a significant tenure at Crown Biosciences, Inc. where they held the positions of Senior Study Director/Scientist II and Study Director/Scientist I in the In Vivo Oncology department. In these roles, they were responsible for designing and executing preclinical oncology studies, including the coordination of animal interventions, clinical measurements, drug administration, and data analysis.

Fernando's academic and research background include working as a Graduate Research Assistant at The University of Texas at Austin from 2015 to 2020, where they were also pursuing a PhD in Pharmaceutical Sciences with a focus on Pharmacology/Toxicology at the College of Pharmacy. During their time at the university, they also served as a Teacher Assistant.

Apart from their industry and academic experience, Fernando has worked in various other roles such as a Practicum Associate at Jon Brumley Texas Venture Labs in 2016, an AP Chemistry Teacher at The American School Foundation from 2013 to 2015, and a Research Intern at Mitacs in 2013.

Earlier in their career, Fernando worked as a Laboratory Assistant at the Instituto Nacional de Neurología y Neurocirugía in 2012, and as a Laboratory Assistant at the Instituto Nacional de Pediatría from 2009 to 2012. In the latter role, they provided technical assistance in data acquisition.

Overall, Fernando Eguiarte-Solomon has extensive experience in the field of oncology and pharmaceutical sciences, with a strong background in study design, data analysis, and research coordination.

Fernando Eguiarte-Solomon's education history can be summarized as follows:

From 2004 to 2007, Fernando obtained a Teacher's Diploma from Colegio Miraflores. Following that, they pursued a Bachelor's Degree in Biological and Pharmaceutical Chemistry from 2009 to 2013 at Universidad Nacional Autónoma de México.

In 2011, Fernando participated as an exchange student at Université de Montréal, where their focus of study was Pharmacology.

Subsequently, from 2015 to 2020, Fernando attended The University of Texas at Austin, College of Pharmacy, earning a PhD in Pharmaceutical Sciences with a specialization in the Molecular Carcinogenesis division.

Additionally, there is information about an additional certification in Systems Biology from Mount Sinai's Icahn School of Medicine. Unfortunately, there are no specific details regarding when this certification was obtained.